| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0879 |
| Trial ID | ChiCTR2000035631 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | A clinical compartive study of autologous CD19 CAR-T cells alone and its sequential ASCT in the treatment of relapsed and refractory B-cell lymphoma ------Multi-center, randomized, open clinical controlled study |
| Year | 2020 |
| Country | China |
| Company sponsor | Xin Hua Hospital Affiliated to Shanghai Jiaotong University School of Medicine |
| Cohort 1 | |||||
|
|||||